Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.

Gender-affirming hormone therapy in primary care is associated with lower rates of depressive symptoms in US transgender, nonbinary, and gender-diverse adults over 4 years of follow-up.

Haemolytic disease of the fetus and newborn (HDFN) occurs when there is transplacental passage of maternal immunoglobulin G ...

Lancaster University researchers are driving forward a project to improve online support for stroke and neurology patients across the region.The ...

Freddie Freeman's family suffered devastating news when almost a year ago, his four-year-old son Max was diagnosed with Guillain-Barre syndrome after being hospitalized. Max suffer ...

Pentec Health, Inc. has announced the launch of prescription digital therapeutic (PDT) services through its newly formed division, Pentec Home Medical. This initiative includes a strategic partnership ...

The following is a summary of “Brain functional connectivity changes on fMRI in patients with chronic pelvic pain treated ...